| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | +3348.1% |
| R&D Expense | $19K | -91.1% |
| SG&A Expense | $1.1M | +69.5% |
| Operating Income | -$21.7M | -108.3% |
| Pre-tax Income | -$33.2M | -104.0% |
| Net Income | -$33.2M | -104.0% |
| EPS (Basic) | -$2.03 | +91.1% |
| EPS (Diluted) | -$2.15 | +92.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | +4418.7% |
| Current Assets | $33.5M | +2463.0% |
| Total Assets | $195.0M | +1711.3% |
| Current Liabilities | $8.0M | +84.9% |
| Total Liabilities | $8.0M | +71.7% |
| Stockholders' Equity | $187.0M | +2959.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.4M | -174.0% |
| Investing Cash Flow | -$115.5M | -6077.8% |
| Financing Cash Flow | $151.7M | +4102.9% |